[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341883-105":59,"doc-detail-341883-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-plasma-ebv-dna-load-with-il-6-and-vegf-levels-as-predictive-and-prognostic-biomarker-in-nasopharyngeal-carcinoma-abstract-and-study-findings","The plasma EBV DNA load with IL-6 and VEGF levels as predictive and prognostic biomarker in nasopharyngeal carcinoma - Abstract and study findings","","Nasopharyngeal carcinoma (NPC) is often diagnosed at an advanced stage due to its location and non-specific initial symptoms, and no clinically useful serological marker has been established for early detection. The study evaluates whether plasma Epstein–Barr virus (EBV) DNA load together with interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF) can serve as a serological marker for early detection and for predicting treatment response. Plasma EBV DNA, IL-6, and VEGF were measured in 24 NPC patients at diagnosis and during/after therapy. High EBV DNA load correlated with elevated IL-6 and VEGF, linking with therapeutic response; persistent/recurrent levels may predict progression and guide additional therapy and longer follow-up.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-plasma-ebv-dna-load-with-il-6-and-vegf-levels-as-predictive-and-prognostic-biomarker-in-nasopharyngeal-carcinoma-abstract-and-study-findings/341883/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-plasma-ebv-dna-load-with-il-6-and-vegf-levels-as-predictive-and-prognostic-biomarker-in-nasopharyngeal-carcinoma-abstract-and-study-findings/341883.png","ImageObject",300,407,{"name":92,"@type":93},"Riley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why are serological markers important for nasopharyngeal carcinoma (NPC)?","Question",{"text":113,"@type":114},"NPC is frequently diagnosed at an advanced stage because early symptoms are non-specific. The study notes that no clinically useful serological marker had been established for early detection.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What biomarkers were measured in the patients?",{"text":118,"@type":114},"Plasma EBV DNA load, interleukin-6 (IL-6) level, and vascular endothelial growth factor (VEGF) expressions were measured in 24 NPC patients at presentation and at multiple time points during and after treatment.",{"name":120,"@type":111,"acceptedAnswer":121},"How did the biomarkers relate to treatment response and disease progression?",{"text":122,"@type":114},"Higher plasma EBV DNA load showed a positive correlation with higher IL-6 and VEGF expression and was closely associated with therapeutic response. Persistent or recurrent EBV DNA with higher IL-6 and VEGF levels may predict disease progression and help select patients for additional therapy and longer follow-up.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},341883,1790196421,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","Ghose etal. Virology Journal (2024) 21:224 [https://doi.org/10.1186/s12985-024-02473-0](https://doi.org/10.1186/s12985-024-02473-0)  \nVirology Journal  \n RESEARCH Open Access  \nThe plasma EBV DNA load with IL-6    \nand VEGF levels as predictive and prognostic biomarker in nasopharyngeal carcinoma  \nSampa Ghose1*, Swarnaditya Roy2, Vivek Ghosh2, Surender K. Sharawat 1, Raja Pramanik 1, Subhrajit Biswas3 and Ahitagni Biswas2  \nAbstract  \nNasopharyngeal carcinoma (NPC) is often diagnosed at a very advanced stage due to its location and non-specific initial symptoms. Moreover, no clinically useful serological marker has been established so far for early detection of NPC. In this study, we have investigated the clinical significance of plasma Epstein–Barr virus DNA load along with interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF) levels to evaluate if these three all together can be useful as a strong serological marker for early detection and prediction of treatment response in patients with NPC. Plasma EBV DNA load, IL-6 level, VEGF expressions were measured in 24 patients with NPC at presentation and various time points during and after treatment. There was a positive correlation between high plasma EBV DNA load with higher IL-6 and VEGF expression, which was closely associated with therapeutic response as well. Persistent or recurrent plasma EBV load with higher IL-6 and VEGF levels can potentially predict disease progression and may be useful to select patients for additional therapy and longer follow-up.  \nKeywords Nasopharyngeal carcinoma (NPC), Epstein Barr virus (EBV), Interleukin-6 (IL-6), Vascular endothelial growth factor (VEGF), Biomarkers  \nIntroduction  \nNasopharyngeal carcinoma is a complex disease, found to be associated with chronic infection by oncogenic gamma herpes virus Epstein–Barr virus [31]. Due to late diagnosis, the overall survival (OS) rate is less than 40% for 5 years in NPC patients [26]. Several clinico-pathological factors such as age, sex, tumor stage, grade, sensitivity to chemotherapy as well as radiotherapy affect  \n*Correspondence:  \nSampa Ghose [sampaghose@gmail.com](sampaghose@gmail.com)  \n1 Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi 110029, India  \n2 Department of Radiotherapy and Oncology, All India Institute of Medical Sciences, New Delhi, India  \n3 Amity Institute of Molecular Medicine and Stem Cell Research, Amity University, Noida, UP, India  \noverall survival. The severity of NPC is also closely associated with EBV DNA load due to chronic active EBV infection. Many biopsy specimens from nasopharyngeal carcinoma contain EBV [20]. Our previous studies have showed that the majority of NPC patients were EBV positive at presentation and the DNA load of plasma EBV (copy numbers per milliliter) was closely associated with the disease stage [22].  \nIt is well established that EBV-encoded genes are involved in the regulation of various cellular signaling cascades including immune evasion, which protects infected cells from immunologic attack and trigger carcinogenesis. All EBV-infected NPC cells exhibit type II latency with the expression of EBV-associated nuclear antigen-1 (EBNA1) and EBV-encoded small RNA (EBER), which play important roles in immune evasion [15] . Since EBNA1 maintains the replication of EBV  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Cre","cbCaitbCyw4DIKvA","https://ap.wps.com/l/cbCaitbCyw4DIKvA","pdf",1268100,"English","## Abstract\n## Introduction","[{\"question\":\"Why are serological markers important for nasopharyngeal carcinoma (NPC)?\",\"answer\":\"NPC is frequently diagnosed at an advanced stage because early symptoms are non-specific. The study notes that no clinically useful serological marker had been established for early detection.\"},{\"question\":\"What biomarkers were measured in the patients?\",\"answer\":\"Plasma EBV DNA load, interleukin-6 (IL-6) level, and vascular endothelial growth factor (VEGF) expressions were measured in 24 NPC patients at presentation and at multiple time points during and after treatment.\"},{\"question\":\"How did the biomarkers relate to treatment response and disease progression?\",\"answer\":\"Higher plasma EBV DNA load showed a positive correlation with higher IL-6 and VEGF expression and was closely associated with therapeutic response. Persistent or recurrent EBV DNA with higher IL-6 and VEGF levels may predict disease progression and help select patients for additional therapy and longer follow-up.\"}]","The plasma EBV DNA load with IL-6 and VEGF levels as predictive and prognostic biomarker in nasopharyngeal carcinoma - Abstract and study findings | PDF",1790044258,25,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e97d6fd2739d6099a959cfd110899cca.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9f8b7a58fb289e30d5770096b3847969.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dbf61e844b1fff3d23d168039b578615.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/17c04970a536ba255688573a456579a6.webp",980,1301]